Gain Therapeutics, Inc. ( GANX) - Stock Earnings
GANX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 11, 2026, midnight | — / — | — | — / — | — |
GANX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -4.5 million USD | — USD |
| 2026Q1 | -5.6 million USD | — USD |
| 2026Q2 | -4.7 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
GANX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -22.3 million USD | 55180 USD |
| 2024 | -20.4 million USD | — USD |
| 2025 | -20.2 million USD | — USD |
| 2026 Est. | — | — |
GANX
Price: $1.26
52 week price:
Earnings Per Share: -0.50 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 17900
Market Capitalization: 71.2 million